210 likes | 569 Views
GlucoTrack. Presents. TM. the ultimate, truly non-invasive glucose monitor. Conceptual measurement. Combined technologies:. Estimated reliability level: at least as good as current (invasive) devices. Ultra Sound. Conductivity. Heat capacity. Simultaneous measurement.
E N D
GlucoTrack Presents TM the ultimate, truly non-invasive glucose monitor
Conceptual measurement • Combined technologies: • Estimated reliability level: at least as good as current (invasive) devices. • Ultra Sound • Conductivity • Heat capacity • Simultaneous measurement Company profile
Current Model Just Clip and Click!™ Company profile
GlucoTrack Presents TM the ultimate, truly non-invasive glucose monitor
Award Winner: 2008 Product Innovation Leadership of the Year Company profile
Market volume & growth rate (Source: IDF) • Over 246 million (known) diabetics • Above 7% of adult population are diabetics Company profile
UK Market volume - 2007 (Source: NHS) UK average = 3.66 % Known diagnosed population in the UK is about 2.3 million people Company profile
GlucoTrack- Unique Approach • Three independent methods, simultaneously • Requires infrequent calibrations Once a month (simple process) • Spot and Continuous measurements Continuous mode in next generation • Extreme values alerts, preset by theuser Company profile
Current Model Just Clip and Click!™ Company profile
Invasive Solutions • Pricking the fingertip • Draw blood • Plug a stick into device • Read result • Same technology for many years • New features and “gadgets”. Company profile
Current Model (Model DF-F) Just Clip and Click!™ Company profile
Current status • Upgraded device: • Modified Ear Clip • Modified calibration algorithm • New measurement algorithm in final stages • New set of clinical trials to begin soon • Strong conceptual patent (registered) • Further patents in process Company profile
Clarke Error Grid Analysis Company profile
GlucoTrack - Clarke Error Grid Results Total Examinees: 85 Total Points: 710 Zones A+B: 91% Zone A: 47% Zone B: 44% Company profile
Your track to health!...™ www.integrity-app.com
Market volume & growth rate (Source: IDF) • Over 246 million (known) diabetics • Above 7% of adult population are diabetics • Market volume: ~$9B per year Company profile
Next activities • Improvement of final product • New set of clinical trials • IP expansion (Patents, Trade marks) • Regulatory process • Discussions with leading distributors (Europe and USA) • CE Mark acquiring • FDA approval (PMA) • Next generation development • New models development Fund to be acquired : $3M Company profile
Cost Effective We estimate enormous savings for patients & health services worldwide. Comparisons of SMBG for the UK can be illustrated as follow:- A diabetes patient with a life span of -10 / 20/ 30 years from diagnosis. Invasive testing SMBG just three times a day. £0.50 per test x 3 = £1.50 x 365 days = £547.50 annual cost. 10 year life expectancy = £5475.00. 20 year life expectancy = £10950.00. 30 year life expectancy = £16425.00. GlucoTrack SMBG as often as desired or required 2000 Euros outright purchase cost = £1670(£/E rate 1.2) + 2 PECs P.A @ £40 each. 10 year life expectancy = £800 (PECS) + UM £1670 = £2470.00. 20 year life expectancy = £1600 (PECS) + UM £1670 = £3270.00. 30 year life expectancy = £2400 (PECS) + UM £1670 = £4070.00. (exclusive of VAT). Company profile